Webcast is Live at 4:00 p.m. (CT)
EDEN PRAIRIE, Minn.--(BUSINESS WIRE)--Oct. 30, 2014--
SurModics, Inc. (Nasdaq:SRDX), a leading provider of surface
modification and in vitro diagnostic technologies to the healthcare
industry, announced today that it will host a live webcast of its fourth
quarter and fiscal year 2014 conference call on Thursday, November 6, at
4:00 p.m. CT (5:00 p.m. ET). The Company will issue an earnings news
release after the market closes that afternoon.
Gary Maharaj, president and chief executive officer, and Andy LaFrence,
vice president of finance and chief financial officer, will recap the
fourth quarter and fiscal year 2014 financial results and
accomplishments as well as provide fiscal 2015 guidance. To access the
webcast, go to the investor relations portion of the Company’s website
at www.surmodics.com
the day of the conference call and click on the webcast icon.
An audio replay will be available beginning at 7:00 p.m. CT on Thursday,
November 6, until 7:00 p.m. CT on Thursday, November 13, and can be
accessed by dialing 888-203-1112 and entering conference call ID
passcode 5965883. In addition, the conference call audio and transcript
will be archived on the Company’s website following the call.
About SurModics, Inc.
SurModics’ mission is to exceed our customers’ expectations and enhance
the well-being of patients by providing the world’s foremost, innovative
surface modification technologies and in vitro diagnostic
chemical components. The Company partners with the world’s leading and
emerging medical device, diagnostic and life science companies to
develop and commercialize innovative products designed to improve
patient diagnosis and treatment. Core offerings include surface
modification coating technologies that impart lubricity, prohealing, and
biocompatibility capabilities; and components for in vitro
diagnostic test kits and microarrays. SurModics is headquartered in Eden
Prairie, Minnesota. For more information about the Company, visit www.surmodics.com.
The content of SurModics’ website is not part of this press release or
part of any filings that the Company makes with the SEC.
Source: SurModics, Inc.
SurModics, Inc.
Andy LaFrence, 952-500-7000
ir@surmodics.com
